annual EBITDA:
$626.23M+$327.40M(+109.56%)Summary
- As of today (September 12, 2025), BMRN annual EBITDA is $626.23 million, with the most recent change of +$327.40 million (+109.56%) on December 31, 2024.
- During the last 3 years, BMRN annual EBITDA has risen by +$589.53 million (+1606.35%).
- BMRN annual EBITDA is now at all-time high.
Performance
BMRN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$320.07M+$67.09M(+26.52%)Summary
- As of today (September 12, 2025), BMRN quarterly EBITDA is $320.07 million, with the most recent change of +$67.09 million (+26.52%) on June 30, 2025.
- Over the past year, BMRN quarterly EBITDA has increased by +$190.15 million (+146.35%).
- BMRN quarterly EBITDA is now at all-time high.
Performance
BMRN quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$907.83M+$190.15M(+26.49%)Summary
- As of today (September 12, 2025), BMRN TTM EBITDA is $907.83 million, with the most recent change of +$190.15 million (+26.49%) on June 30, 2025.
- Over the past year, BMRN TTM EBITDA has increased by +$541.94 million (+148.11%).
- BMRN TTM EBITDA is now at all-time high.
Performance
BMRN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BMRN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +109.6% | +146.3% | +148.1% |
| 3 y3 years | +1606.3% | +469.1% | +2069.8% |
| 5 y5 years | +7459.6% | +1425.5% | +993.0% |
BMRN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1606.3% | at high | >+9999.0% | at high | +2069.8% |
| 5 y | 5-year | at high | +7459.6% | at high | +851.0% | at high | >+9999.0% |
| alltime | all time | at high | +326.6% | at high | +390.6% | at high | +415.3% |
BMRN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $320.07M(+26.5%) | $907.83M(+26.5%) |
| Mar 2025 | - | $252.98M(+56.4%) | $717.69M(+25.5%) |
| Dec 2024 | $626.23M(+109.6%) | $161.73M(-6.5%) | $571.64M(+16.6%) |
| Sep 2024 | - | $173.06M(+33.2%) | $490.44M(+34.0%) |
| Jun 2024 | - | $129.92M(+21.5%) | $365.89M(+15.0%) |
| Mar 2024 | - | $106.93M(+32.8%) | $318.16M(+6.7%) |
| Dec 2023 | $298.83M(+166.4%) | $80.53M(+66.0%) | $298.12M(+38.8%) |
| Sep 2023 | - | $48.52M(-41.0%) | $214.77M(+25.1%) |
| Jun 2023 | - | $82.19M(-5.4%) | $171.66M(+17.8%) |
| Mar 2023 | - | $86.89M(-3183.3%) | $145.71M(+30.1%) |
| Dec 2022 | $112.18M(+205.7%) | -$2.82M(-152.2%) | $112.02M(+55.1%) |
| Sep 2022 | - | $5.40M(-90.4%) | $72.22M(+72.6%) |
| Jun 2022 | - | $56.24M(+5.7%) | $41.84M(+29.6%) |
| Mar 2022 | - | $53.20M(-224.8%) | $32.27M(-2.1%) |
| Dec 2021 | $36.70M(+3533.7%) | -$42.62M(+70.6%) | $32.98M(-53.5%) |
| Sep 2021 | - | -$24.98M(-153.5%) | $70.94M(+13.2%) |
| Jun 2021 | - | $46.67M(-13.4%) | $62.67M(-868.5%) |
| Mar 2021 | - | $53.90M(-1257.4%) | -$8.15M(-984.4%) |
| Dec 2020 | $1.01M(-111.9%) | -$4.66M(-86.0%) | $922.00K(-88.6%) |
| Sep 2020 | - | -$33.25M(+37.7%) | $8.05M(-90.3%) |
| Jun 2020 | - | -$24.15M(-138.3%) | $83.06M(+1.9%) |
| Mar 2020 | - | $62.98M(+2443.5%) | $81.50M(+6287.2%) |
| Dec 2019 | -$8.51M(-86.5%) | $2.48M(-94.1%) | $1.28M(-102.5%) |
| Sep 2019 | - | $41.75M(-262.4%) | -$50.82M(-36.0%) |
| Jun 2019 | - | -$25.70M(+49.0%) | -$79.36M(+11.8%) |
| Mar 2019 | - | -$17.25M(-65.2%) | -$71.00M(+11.0%) |
| Dec 2018 | -$63.15M(+33.7%) | -$49.62M(-475.6%) | -$63.98M(+50.1%) |
| Sep 2018 | - | $13.21M(-176.2%) | -$42.64M(-16.7%) |
| Jun 2018 | - | -$17.34M(+69.5%) | -$51.16M(-6.0%) |
| Mar 2018 | - | -$10.23M(-63.8%) | -$54.41M(+15.3%) |
| Dec 2017 | -$47.22M(-74.0%) | -$28.28M(-703.1%) | -$47.21M(-46.7%) |
| Sep 2017 | - | $4.69M(-122.8%) | -$88.58M(-30.4%) |
| Jun 2017 | - | -$20.59M(+580.8%) | -$127.22M(+20.6%) |
| Mar 2017 | - | -$3.02M(-95.7%) | -$105.48M(-38.6%) |
| Dec 2016 | -$181.79M(-34.2%) | -$69.65M(+105.1%) | -$171.73M(-19.1%) |
| Sep 2016 | - | -$33.95M(-3067.8%) | -$212.21M(-14.5%) |
| Jun 2016 | - | $1.14M(-101.7%) | -$248.32M(-13.7%) |
| Mar 2016 | - | -$69.27M(-37.1%) | -$287.89M(+4.5%) |
| Dec 2015 | -$276.31M(+118.7%) | -$110.13M(+57.2%) | -$275.48M(+32.9%) |
| Sep 2015 | - | -$70.05M(+82.3%) | -$207.28M(+13.7%) |
| Jun 2015 | - | -$38.43M(-32.4%) | -$182.25M(+24.6%) |
| Mar 2015 | - | -$56.86M(+35.6%) | -$146.25M(+39.9%) |
| Dec 2014 | -$126.35M(+15.0%) | -$41.93M(-6.9%) | -$104.52M(+6.2%) |
| Sep 2014 | - | -$45.02M(+1749.1%) | -$98.46M(+21.9%) |
| Jun 2014 | - | -$2.44M(-83.9%) | -$80.75M(-8.6%) |
| Mar 2014 | - | -$15.13M(-57.8%) | -$88.37M(-2.3%) |
| Dec 2013 | -$109.89M(+59.1%) | -$35.87M(+31.3%) | -$90.44M(+14.4%) |
| Sep 2013 | - | -$27.32M(+171.7%) | -$79.05M(+54.5%) |
| Jun 2013 | - | -$10.05M(-41.5%) | -$51.15M(-20.3%) |
| Mar 2013 | - | -$17.20M(-29.7%) | -$64.15M(+8.6%) |
| Dec 2012 | -$69.06M(-1681.4%) | -$24.48M(-4291.6%) | -$59.08M(+136.6%) |
| Sep 2012 | - | $584.00K(-102.5%) | -$24.98M(+54.1%) |
| Jun 2012 | - | -$23.05M(+90.0%) | -$16.21M(-207.3%) |
| Mar 2012 | - | -$12.13M(-226.0%) | $15.11M(-61.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $4.37M(-82.9%) | $9.63M(+3.0%) | $39.61M(+8.4%) |
| Sep 2011 | - | $9.35M(+13.1%) | $36.53M(+9.0%) |
| Jun 2011 | - | $8.27M(-33.1%) | $33.51M(+24.9%) |
| Mar 2011 | - | $12.36M(+88.7%) | $26.82M(+39.6%) |
| Dec 2010 | $25.57M(-31.8%) | $6.55M(+3.6%) | $19.21M(+51.7%) |
| Sep 2010 | - | $6.33M(+300.3%) | $12.66M(+13.3%) |
| Jun 2010 | - | $1.58M(-66.8%) | $11.18M(-44.3%) |
| Mar 2010 | - | $4.76M(>+9900.0%) | $20.08M(+26.9%) |
| Dec 2009 | $37.47M(-34.7%) | $0.00(-100.0%) | $15.83M(-67.7%) |
| Sep 2009 | - | $4.84M(-53.8%) | $48.98M(-4.0%) |
| Jun 2009 | - | $10.48M(+1988.2%) | $51.04M(+3.0%) |
| Mar 2009 | - | $502.00K(-98.5%) | $49.54M(-7.8%) |
| Dec 2008 | $57.39M(-231.2%) | $33.15M(+380.1%) | $53.72M(+336.9%) |
| Sep 2008 | - | $6.91M(-23.1%) | $12.30M(-242.7%) |
| Jun 2008 | - | $8.98M(+91.6%) | -$8.62M(-69.1%) |
| Mar 2008 | - | $4.69M(-156.6%) | -$27.89M(-39.8%) |
| Dec 2007 | -$43.74M(+36.8%) | -$8.28M(-40.9%) | -$46.35M(-12.1%) |
| Sep 2007 | - | -$14.01M(+36.2%) | -$52.75M(+21.6%) |
| Jun 2007 | - | -$10.29M(-25.3%) | -$43.39M(+18.0%) |
| Mar 2007 | - | -$13.78M(-6.1%) | -$36.78M(+15.2%) |
| Dec 2006 | -$31.99M(-51.5%) | -$14.67M(+215.6%) | -$31.92M(+1.3%) |
| Sep 2006 | - | -$4.65M(+26.4%) | -$31.52M(-22.7%) |
| Jun 2006 | - | -$3.68M(-58.8%) | -$40.78M(-28.5%) |
| Mar 2006 | - | -$8.92M(-37.5%) | -$57.06M(-15.4%) |
| Dec 2005 | -$65.98M(+4.0%) | -$14.27M(+2.5%) | -$67.47M(-2.1%) |
| Sep 2005 | - | -$13.91M(-30.3%) | -$68.91M(-4.3%) |
| Jun 2005 | - | -$19.96M(+3.2%) | -$72.00M(+10.2%) |
| Mar 2005 | - | -$19.34M(+23.2%) | -$65.34M(+6.5%) |
| Dec 2004 | -$63.41M(+6.1%) | -$15.70M(-7.7%) | -$61.33M(-10.3%) |
| Sep 2004 | - | -$17.01M(+27.9%) | -$68.36M(-1.1%) |
| Jun 2004 | - | -$13.30M(-13.2%) | -$69.09M(-1.2%) |
| Mar 2004 | - | -$15.32M(-32.6%) | -$69.94M(-4.3%) |
| Dec 2003 | -$59.77M(+29.4%) | -$22.73M(+28.1%) | -$73.10M(+15.2%) |
| Sep 2003 | - | -$17.74M(+25.3%) | -$63.43M(+8.4%) |
| Jun 2003 | - | -$14.15M(-23.4%) | -$58.50M(+5.7%) |
| Mar 2003 | - | -$18.48M(+41.5%) | -$55.35M(+14.4%) |
| Dec 2002 | -$46.17M(+35.3%) | -$13.06M(+2.0%) | -$48.37M(-12.2%) |
| Sep 2002 | - | -$12.81M(+16.4%) | -$55.09M(+10.3%) |
| Jun 2002 | - | -$11.01M(-4.3%) | -$49.96M(+5.8%) |
| Mar 2002 | - | -$11.50M(-41.8%) | -$47.24M(+8.3%) |
| Dec 2001 | -$34.13M(+26.2%) | -$19.77M(+157.5%) | -$43.63M(+111.8%) |
| Sep 2001 | - | -$7.68M(-7.3%) | -$20.61M(-5.3%) |
| Jun 2001 | - | -$8.29M(+4.9%) | -$21.75M(+12.5%) |
| Mar 2001 | - | -$7.90M(-342.5%) | -$19.32M(+10.4%) |
| Dec 2000 | -$27.05M(+21.4%) | $3.26M(-136.9%) | -$17.50M(-25.6%) |
| Sep 2000 | - | -$8.82M(+50.5%) | -$23.52M(+4.0%) |
| Jun 2000 | - | -$5.86M(-3.5%) | -$22.63M(-2.4%) |
| Mar 2000 | - | -$6.08M(+119.8%) | -$23.18M(+10.4%) |
| Dec 1999 | -$22.28M(+80.1%) | -$2.76M(-65.1%) | -$20.99M(+15.2%) |
| Sep 1999 | - | -$7.93M(+23.6%) | -$18.23M(+76.9%) |
| Jun 1999 | - | -$6.41M(+64.7%) | -$10.30M(+164.7%) |
| Mar 1999 | - | -$3.89M | -$3.89M |
| Dec 1998 | -$12.37M(+338.2%) | - | - |
| Dec 1997 | -$2.82M | - | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual EBITDA?
- What is the all time high annual EBITDA for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual EBITDA year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly EBITDA year-on-year change?
- What is BioMarin Pharmaceutical Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. TTM EBITDA year-on-year change?
What is BioMarin Pharmaceutical Inc. annual EBITDA?
The current annual EBITDA of BMRN is $626.23M
What is the all time high annual EBITDA for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual EBITDA is $626.23M
What is BioMarin Pharmaceutical Inc. annual EBITDA year-on-year change?
Over the past year, BMRN annual EBITDA has changed by +$327.40M (+109.56%)
What is BioMarin Pharmaceutical Inc. quarterly EBITDA?
The current quarterly EBITDA of BMRN is $320.07M
What is the all time high quarterly EBITDA for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly EBITDA is $320.07M
What is BioMarin Pharmaceutical Inc. quarterly EBITDA year-on-year change?
Over the past year, BMRN quarterly EBITDA has changed by +$190.15M (+146.35%)
What is BioMarin Pharmaceutical Inc. TTM EBITDA?
The current TTM EBITDA of BMRN is $907.83M
What is the all time high TTM EBITDA for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high TTM EBITDA is $907.83M
What is BioMarin Pharmaceutical Inc. TTM EBITDA year-on-year change?
Over the past year, BMRN TTM EBITDA has changed by +$541.94M (+148.11%)